December 20, 2018 - Page 15 of 25

Canadian Stock Exchange News - December 20, 2018

Glance Technologies Files Provisional Patent for Blockchain Technology With USPTO

VANCOUVER, British Columbia, Dec. 20, 2018 (GLOBE NEWSWIRE) — Glance Technologies Inc. (“Glance” or the “Company”) (CSE:GET.CN) (OTCQB:GLNNF) (FKT:GJT) is […]

NYSE Companies - December 20, 2018

Global Ship Lease Announces Results of Consent Solicitation for 9.875% First Priority Secured Notes due 2022

LONDON, Dec. 20, 2018 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE: GSL) (the “Company”) today announced that it has […]

NASDAQ Companies - December 20, 2018

Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53

— Golodirsen has been studied for the treatment of exon 53 amenable patients, approximately eight percent of patients with Duchenne […]

NASDAQ Companies - December 20, 2018

Inpixon On Track to Ship Record Number of IPA Sensor 4000SE in Q4

PALO ALTO, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) — Inpixon (Nasdaq: INPX), a leading indoor positioning and data analytics company, […]

NASDAQ Companies - December 20, 2018

Galectin Therapeutics Announces Extension of $10 Million Line Credit

NORCROSS, Ga., Dec. 20, 2018 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target […]

NASDAQ Companies - December 20, 2018

Core-Mark Announces Executive Appointments

Company creates new Enterprise Growth position; names new heads for Eastern and Western Divisions SOUTH SAN FRANCISCO, Calif., Dec. 20, […]

NASDAQ Companies - December 20, 2018

Adverum to Present at the 37th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting […]